149 related articles for article (PubMed ID: 1394345)
1. T lymphocyte killing by a xanthine-oxidase-containing immunotoxin.
Battelli MG; Abbondanza A; Tazzari PL; Bolognesi A; Lemoli RM; Stirpe F
Cancer Immunol Immunother; 1992; 35(6):421-5. PubMed ID: 1394345
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity of an oxygen-radical-generating enzyme conjugated to a monoclonal antibody.
Battelli MG; Abbondanza A; Tazzari PL; Dinota A; Rizzi S; Grassi G; Gobbi M; Stirpe F
Clin Exp Immunol; 1988 Jul; 73(1):128-33. PubMed ID: 3262464
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH
Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
[TBL] [Abstract][Full Text] [Related]
4. T cell depletion with anti-CD5 immunotoxin in histocompatible bone marrow transplantation. The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease.
Filipovich AH; Vallera D; McGlave P; Polich D; Gajl-Peczalska K; Haake R; Lasky L; Blazar B; Ramsay NK; Kersey J
Transplantation; 1990 Sep; 50(3):410-5. PubMed ID: 1698319
[TBL] [Abstract][Full Text] [Related]
5. Targeting of a plasma cell line with a conjugate containing xanthine oxidase and the monoclonal antibody 62B1.
Tazzari PL; Battelli MG; Abbondanza A; Dinota A; Rizzi S; Gobbi M; Stirpe F
Transplantation; 1989 Jul; 48(1):119-22. PubMed ID: 2787552
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow purging by a xanthine oxidase-antibody conjugate.
Dinota A; Tazzari PL; Abbondanza A; Battelli MG; Gobbi M; Stirpe F
Bone Marrow Transplant; 1990 Jul; 6(1):31-6. PubMed ID: 2390631
[TBL] [Abstract][Full Text] [Related]
7. The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro.
Meng G; Jiang Y; Hubbard W; Thomas JM
Transpl Immunol; 1998 Mar; 6(1):53-9. PubMed ID: 9640629
[TBL] [Abstract][Full Text] [Related]
8. Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.
Lee SC; Seo KW; Kim HJ; Kang SW; Choi HJ; Kim A; Kwon BS; Cho HR; Kwon B
Cell Transplant; 2015; 24(6):1167-81. PubMed ID: 24594433
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
Collinson AR; Lambert JM; Liu Y; O'Dea C; Shah SA; Rasmussen RA; Goldmacher VS
Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
[TBL] [Abstract][Full Text] [Related]
10. An immunotoxin system intended for bone marrow purging composed of glucose oxidase and lactoperoxidase coupled to monoclonal antibody 097.
Ito HO; Morizet J; Coulombel L; Goavec M; Rousseau V; Bernard A; Stanislawski M
Bone Marrow Transplant; 1989 Sep; 4(5):519-27. PubMed ID: 2790330
[TBL] [Abstract][Full Text] [Related]
11. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
12. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
13. Treatment with immunotoxin.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):681-9. PubMed ID: 11375071
[TBL] [Abstract][Full Text] [Related]
14. Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease.
Martin PJ; Hansen JA; Torok-Storb B; Moretti L; Press O; Storb R; Thomas ED; Weiden PL; Vitetta ES
Bone Marrow Transplant; 1988 Sep; 3(5):437-44. PubMed ID: 2973360
[TBL] [Abstract][Full Text] [Related]
15. Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.
Byers VS; Henslee PJ; Kernan NA; Blazar BR; Gingrich R; Phillips GL; LeMaistre CF; Gilliland G; Antin JH; Martin P
Blood; 1990 Apr; 75(7):1426-32. PubMed ID: 2180494
[TBL] [Abstract][Full Text] [Related]
16. Activation of T lymphocytes for adhesion and cytokine expression by toxin-conjugated anti-CD3 monoclonal antibodies.
Hamawy MM; Tsuchida M; Manthei ER; Dong Y; Fechner JE; Knechtle JS
Transplantation; 1999 Sep; 68(5):693-8. PubMed ID: 10507490
[TBL] [Abstract][Full Text] [Related]
17. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
[TBL] [Abstract][Full Text] [Related]
18. Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naïve baboons.
Wamala I; Matar AJ; Farkash E; Wang Z; Huang CA; Sachs DH
Transpl Immunol; 2013 Dec; 29(1-4):60-3. PubMed ID: 24157659
[TBL] [Abstract][Full Text] [Related]
19. Reduction of graft-versus-host reactivity after small bowel transplantation: ex vivo treatment of intestinal allografts with an anti-T cell immunotoxin.
Clark CL; Smith GJ; Crane PW; Price BA; Lear PA; Fabre JW; Wood RF
Clin Exp Immunol; 1992 May; 88(2):220-5. PubMed ID: 1373997
[TBL] [Abstract][Full Text] [Related]
20. Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin.
Blazar BR; Carroll SF; Vallera DA
Blood; 1991 Dec; 78(11):3093-102. PubMed ID: 1954395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
